Researchers at the Universitat Oberta de Catalunya in Spain and the U.K.'s University of Leicester have designed an antibody to recognize specific proteins on the surface of aged or senescent cells.
Once deployed, it attaches itself to these cells, detonating a drug that removes only the proteins, minimizing potential side effects.
These findings build on previous research using senolytic drugs, which have shown similar success in eliminating senescent cells and delaying age-related decline in animals.
A recent study found that after people turn 108 years old, they have a 50 percent chance of living for another year as each year passes. This, theoretically, suggests there is no limit to the human lifespan - although many biologists disagree.
Read the original story here.
Sign in or become a tippinsights member to join the conversation.
Just enter your email below to get a log in link.